March 3, 2026

Impact of CD19 CAR Product on Resource Utilization through Day 28 for Large Cell Lymphoma

Resource utilization for CD19 CAR therapy showed significant insights by Day 28, impacting treatment protocols.
Key metrics observed included hospitalization days and treatment dosage adjustments as answers to patient needs.
Analysis of clinical data from large cell lymphoma patients revealed pertinent trends in resource allocation and therapeutic impact.
Understanding resource use can help streamline CAR therapies in clinical practice, benefiting patient care and healthcare costs.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

G. L. Shah

Maria Bromberg

Sarah Samordonitsky

Transplantation and Cellular Therapy

University of Pennsylvania

University of Chicago

University of Minnesota

Building similarity graph...

Analyzing shared references across papers